SNCA and Parkinson disease: Twelve studies including 761 PD patients and 503 controls found a significant reduction in a mean difference of total salivary alpha‐synuclein among PD patients as compared to healthy controls [SMD (Hedges' g = −0.77, 95% CI: −1.25 to −0.29, p‐value = <0.001).